Abstract
Correction to Benefits of Early Versus Late Initiation of Intravenous Immunoglobulin in the Treatment of Patients With Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have